Chemotherapy in metastatic prostate cancer experience exchange

Click here for Prescribing Information

Professor Amit Bahl,
Consultant Clinical Oncologist, Spire Oncology Centre South West and Spire Bristol Hospital

How do you define and monitor for disease progression?



Back to questions